Want to see WGS full AI Analyst Report?
GeneDx Holdings (WGS) Income Statement
GeneDx Holdings Income Statement
Last quarter (Q2 2026), GeneDx Holdings's total revenue was $114.44M, an increase of 11.44% from the same quarter last year. In Q2, GeneDx Holdings's net income was $-17.74M. See GeneDx Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 427.54M | $ 305.45M | $ 202.57M | $ 234.69M | $ 212.19M | |
| $ 298.17M | $ 194.40M | $ 90.01M | $ -26.75M | $ -16.60M | |
| $ 311.25M | $ 217.61M | $ 270.60M | $ 640.90M | $ 429.55M | |
| Depreciation and Amortization | $ 25.22M | $ 21.95M | $ 33.73M | $ 59.31M | $ 21.81M |
| $ 6.63M | $ -27.64M | $ -136.46M | $ -398.20M | $ -220.75M | |
| $ -11.80M | $ -23.21M | $ -180.60M | $ -667.65M | $ -446.15M | |
| $ -9.34M | $ -29.42M | $ 3.90M | $ 69.62M | $ 200.76M | |
| $ -21.14M | $ -52.63M | $ -176.69M | $ -598.03M | $ -245.39M | |
| $ -21.02M | $ -52.29M | $ -175.77M | $ -548.98M | $ -245.39M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.73 | $ -1.94 | $ -7.23 | $ -53.63 | $ -74.93 |
| Diluted EPS | $ -0.73 | $ -1.94 | $ -7.23 | $ -53.63 | $ -74.93 |
| Weighted Average Shares Outstanding | 26.89M | 26.89M | 24.31M | 10.24M | 3.28M |
| Weighted Average Shares Outstanding (Diluted) | 26.89M | 26.89M | 24.31M | 10.24M | 3.28M |
Currency in USD
